Sarepta Therapeutics
SRPT
#1513
Rank
โ‚ฌ10.96 B
Marketcap
114,78ย โ‚ฌ
Share price
-0.42%
Change (1 day)
39.21%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

EPS for Sarepta Therapeutics (SRPT)

EPS in 2023 (TTM): -7,21ย โ‚ฌ

According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -7,55ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -7,75ย โ‚ฌ a decrease over its 2021 EPS that were of -4,97ย โ‚ฌ.

EPS history for Sarepta Therapeutics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-7,21ย โ‚ฌ-6.9%
2022-7,75ย โ‚ฌ55.92%
2021-4,97ย โ‚ฌ-27.16%
2020-6,82ย โ‚ฌ-26.96%
2019-9,34ย โ‚ฌ78.6%
2018-5,23ย โ‚ฌ603.9%
2017-0,74ย โ‚ฌ-85.9%
2016-5,27ย โ‚ฌ5.2%
2015-5,01ย โ‚ฌ53.1%
2014-3,27ย โ‚ฌ-0%
2013-3,27ย โ‚ฌ-33.79%
2012-4,94ย โ‚ฌ7214.29%
2011-0,06754ย โ‚ฌ-96.11%
2010-1,74ย โ‚ฌ15.38%
2009-1,51ย โ‚ฌ-23.53%
2008-1,97ย โ‚ฌ-37.04%
2007-3,13ย โ‚ฌ-0%
2006-3,13ย โ‚ฌ45.95%
2005-2,14ย โ‚ฌ-46.38%
2004-3,99ย โ‚ฌ40.82%
2003-2,84ย โ‚ฌ-57.02%
2002-6,60ย โ‚ฌ-2.56%
2001-6,77ย โ‚ฌ138.78%
2000-2,84ย โ‚ฌ-9.52%
1999-3,13ย โ‚ฌ-72.2%
1998-11,28ย โ‚ฌ519.44%
1997-1,82ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
4,24ย โ‚ฌ-156.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-6,94ย โ‚ฌ-8.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,99ย โ‚ฌ-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,21ย โ‚ฌ-84.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-3,97ย โ‚ฌ-47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-8,35ย โ‚ฌ 10.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-5,08ย โ‚ฌ-32.69%๐Ÿ‡บ๐Ÿ‡ธ USA